Verano Holdings (VRNO) Return on Invested Capital (2022 - 2026)
Verano Holdings' (VRNO) quarterly Return on Invested Capital came in at 0.4% in Q1 2026, down 36.0% year-on-year from 0.62% in Q1 2025, and down 215.24% on a QoQ basis from 0.13% in Q4 2025.
Verano Holdings (VRNO) Return on Invested Capital (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Return on Invested Capital data on file, last reported at 0.4% in Q1 2026.
- On a quarterly basis, Return on Invested Capital fell 36.0% year-over-year to 0.4% in Q1 2026; TTM through Mar 2026 was 0.4%, a 36.0% decrease from a year earlier, with the FY2025 full-year figure at 0.18%, up 6.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.4%, down from 0.13% in the prior quarter.
- Over the last five years, Return on Invested Capital for VRNO reached as high as 0.06% in Q3 2024 and fell as low as 0.4% in Q1 2026.
- Historically, Return on Invested Capital has averaged 0.06% across 5 years, with a median of 0.03% in 2024.
- Across the five-year window, Return on Invested Capital advanced 8 bps in 2024 and tumbled 36 bps in 2026, its largest moves.
- Year by year, Return on Invested Capital stood at 0.01% in 2022, then tumbled by 1042 bps to 0.06% in 2023, then surged by 53 bps to 0.03% in 2024, then sank by 322 bps to 0.13% in 2025, then plunged by 215 bps to 0.4% in 2026.
- Per Business Quant data, the three most recent Return on Invested Capital figures were 0.4% in Q1 2026, 0.13% in Q4 2025, and 0.09% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -0.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.40% |
| Dec 31, 2025 | -0.13% |
| Sep 30, 2025 | -0.09% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | 0.06% |
| Jun 30, 2024 | -0.12% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | -0.06% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |